3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this study was to evaluate the pharmacodynamics (PDs), pharmacokinetics (PKs) and safety of lesinurad (selective uric acid reabsorption inhibitor) in combination with febuxostat (xanthine oxidase inhibitor) in patients with gout.

          Related collections

          Author and article information

          Journal
          Rheumatology (Oxford)
          Rheumatology (Oxford, England)
          1462-0332
          1462-0324
          Dec 2014
          : 53
          : 12
          Affiliations
          [1 ] Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA. rfleischmann@mcrcdallas.com.
          [2 ] Metroplex Clinical Research Center, Dallas, TX, Ardea Biosciences and Translational Sciences Department, Clinical Department, Regulatory Department and Biology Department, Ardea Biosciences, San Diego, CA, USA.
          Article
          ket487
          10.1093/rheumatology/ket487
          24509406
          82a18170-536b-47f0-b715-7508e6900b02
          © The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
          History

          drug–drug interaction,febuxostat,gout,lesinurad,pharmacodynamic,pharmacokinetic,selective uric acid reabsorption inhibitor,xanthine oxidase inhibitor

          Comments

          Comment on this article